Shenzhen Salubris Pharmaceuticals Co., Ltd.
002294
Hisse Senetlerindeki Sıralama
#3418
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Hisse Fiyatı
$4.48
Piyasa Değeri
$4.99B
Değişim (1 gün)
-5.20%
Değişim (1 yıl)
-41.89%
Ülke
CN
Ticaret Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Kategori
Healthcare
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294) için EPS
June 2026 itibariyle EPS TTM: $0.09
Shenzhen Salubris Pharmaceuticals Co., Ltd. şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $0.09'dir. 2024 yılı sonunda, şirketin EPS'si $0.07 idi; bu, 2023 yılındaki EPS olan $0.07 ile önceki yıla eşit.
Shenzhen Salubris Pharmaceuticals Co., Ltd. için 2006 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
| Yıl | EPS | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.09 | 12.25% |
| 2025 | $0.08 | 12.03% |
| 2024 | $0.07 | 0.68% |
| 2023 | $0.07 | -12.60% |
| 2022 | $0.08 | 6.86% |
| 2021 | $0.08 | 764.84% |
| 2020 | $0.01 | -90.82% |
| 2019 | $0.10 | -50.96% |
| 2018 | $0.20 | -5.38% |
| 2017 | $0.21 | 11.48% |
| 2016 | $0.19 | 2.84% |
| 2015 | $0.19 | 15.43% |
| 2014 | $0.16 | 23.96% |
| 2013 | $0.13 | 33.13% |
| 2012 | $0.10 | 58.00% |
| 2011 | $0.06 | 20.19% |
| 2010 | $0.05 | 40.71% |
| 2009 | $0.04 | 66.36% |
| 2008 | $0.02 | 71.88% |
| 2007 | $0.01 | 91.04% |
| 2006 | $0.01 | 0.00% |
Benzer şirketler veya rakipler için EPS
| Şirket | EPS | EPS Farkı | Ülke |
|---|---|---|---|
| $8.37 | 9,220.71% |
US
|
|
| $6.41 | 7,032.74% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 3,597.10% |
US
|
|
| - | - |
CH
|
